Investigative Site

Tucson, Arizona 85741

0 studies enrolling now · 9 studies all time

What they study most

Constipation, Covid19, Diabetic Macular Edema, Heavy Menstrual Bleeding, Irritable Bowel Syndrome With Diarrhea (IBS-D), Menorrhagia, Opioid-induced Constipation, Pancreatic Cancer

Studies at this site

• Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients — Completed
• A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME) — Running, not enrolling
• Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19. — Stopped early
• VIR-7831 for the Early Treatment of COVID-19 in Outpatients — Completed
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed
• Efficacy and Safety of XP12B in Women With Menorrhagia — Completed
• Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. — Stopped early
• Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain — Stopped early
• Efficacy and Safety Study of XP12B in Women With Menorrhagia — Completed